Case Report on Nevirapine Induced Exfoliative Dermatitis

Authors

  • R. Rohith Department of Clinical Pharmacy, P Rami Reddy Memorial College of Pharmacy, India
  • R. Siddarama Department of Clinical Pharmacy, P Rami Reddy Memorial College of Pharmacy, India
  • Gangula Amareswara Reddy Department of Clinical Pharmacy, P Rami Reddy Memorial College of Pharmacy, India
  • P. Gowtham Department of Clinical Pharmacy, P Rami Reddy Memorial College of Pharmacy, India
  • R. Phanindra Nayak Department of Clinical Pharmacy, P Rami Reddy Memorial College of Pharmacy, India
  • M. Venkata Subbaiah Department of Pharmacy Practice, P Rami Reddy Memorial College of Pharmacy, Kadapa, India

DOI:

https://doi.org/10.37591/rrjom.v5i2.1490

Abstract

 

Nevirapine is the first drug of non-nucleoside reverse transcriptase inhibitors (NNRTI) class to treat seropositive patients, administered along with protease inhibitors and/or NRTIs. Nevirapine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent polymerase enzyme. Exfoliative dermatitis is wide spread erythema and scaling of skin caused by pre-existing skin disorders, drugs and cancer, unknown causes. HIV infected patients are more prone to Exfoliative Dermatitis. This is a case report of 30 years male seropositive patient admitted in dermatology department with complaints of scaling over the skin since 9 days, and had history of present illness started over the face and then extended to involve the trunk area and flexors the upper limbs and up to mid-thigh. He was taking Zidovudine, Lamivudine and Efavirnz, but by mistake he was dispensed with Nevirapine. The reaction started immediately after taking ZLN regimen. On the day of administration of the drug he developed itching and within 3 days scaly lesions were present over the body. He had a past history of similar complaints on intake of nevirapine. The lesions were erythematous and scaly plagues were present over the face, neck, trunk and back. The patient was diagnosed as Nevirapine induced Exfoliative Dermatitis. De-challenge test was done and we performed ADR analysis which proved it as probable ADR.

 

Keywords:  exfoliative dermatitis, nevirapine, enzyme, reverse transcriptase inhibitors

Cite this Article

R Rohith, R Siddarama, Gangula Amareswara Reddy et. al. Case Report On Nevirapine Induced Exfoliative Dermatitis, Research and Reviews: Journal of Medicine, 2015; 5(2): 7–10p.

Downloads

Published

2019-04-19

Issue

Vol. 5 No. 2 (2015)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.